Cerebrovascular perfusion in marijuana users during a month of monitored abstinence

Objective: To determine possible effects of prolonged marijuana use on the cerebrovascular system during a month of monitored abstinence and to assess how the intensity of current use might have influenced cerebrovascular perfusion in these marijuana users. Method: The authors recorded blood flow velocity in the anterior and middle cerebral arteries using transcranial Doppler sonography in three groups of marijuana users who differed in the intensity of recent use (light: n = 11; moderate: n = 23; and heavy: n = 20) and in control subjects (n = 18) to assess the nature and duration of any potential abnormalities. Blood flow velocity was recorded within 3 days of admission and 28 to 30 days of monitored abstinence on an inpatient research unit in order to evaluate subacute effects of the drug and any abstinence-generated changes. Results: Pulsatility index, a measure of cerebrovascular resistance, and systolic velocity were significantly increased in the marijuana users vs control subjects. These increases persisted in the heavy marijuana users after a month of monitored abstinence. Conclusions: Chronic marijuana use is associated with increased cerebrovascular resistance through changes mediated, in part, in blood vessels or in the brain parenchyma. These findings might provide a partial explanation for the cognitive deficits observed in a similar group of marijuana users.

[1]  Stephan Arndt,et al.  Effects of frequent marijuana use on memory-related regional cerebral blood flow , 2002, Pharmacology Biochemistry and Behavior.

[2]  R. Fahlbusch,et al.  Cerebral hemodynamics in subarachnoid hemorrhage evaluated by transcranial Doppler sonography. Part 2. Pulsatility indices: normal reference values and characteristics in subarachnoid hemorrhage. , 1994, Neurosurgery.

[3]  R. Herning,et al.  Neurovascular Deficits in Cocaine Abusers , 1999, Neuropsychopharmacology.

[4]  M. Sasaki,et al.  PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  R. Herning,et al.  Clinical Relevance of Cannabis Tolerance and Dependence , 1981, Journal of clinical pharmacology.

[6]  D. Kosinski,et al.  Cerebral Syncope: Loss of Consciousness Associated with Cerebral Vasoconstriction in the Absence of Systemic Hypotension , 1998, Pacing and clinical electrophysiology : PACE.

[7]  Reese T. Jones Cardiovascular System Effects of Marijuana , 2002, Journal of clinical pharmacology.

[8]  N. Shephard,et al.  Bioavailability of potassium from controlled-release tablets with and without water loading , 2004, European Journal of Clinical Pharmacology.

[9]  T. Glenn,et al.  Transcranial Doppler Pulsatility Indices as a Measure of Diffuse Small‐Vessel Disease , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[10]  Y. Sohn,et al.  Arterial pulsatility as an index of cerebral microangiopathy in diabetes. , 2000, Stroke.

[11]  James Provenzale,et al.  Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography , 2002, Psychiatry Research: Neuroimaging.

[12]  D. Amen,et al.  High resolution brain SPECT imaging of marijuana smokers with AD/HD. , 1998, Journal of psychoactive drugs.

[13]  R. Herning,et al.  How a cigarette is smoked determines blood nicotine levels , 1983, Clinical pharmacology and therapeutics.

[14]  Hans Förstl,et al.  Senile dementia of Alzheimer type and multi-infarct dementia investigated by transcranial Doppler sonography. , 1996, Dementia.

[15]  A. Alexandrov,et al.  Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology* , 2004, Neurology.

[16]  G. Kim,et al.  Blood flow velocity changes in the middle cerebral artery as an index of the chronicity of hypertension , 1997, Journal of the Neurological Sciences.

[17]  J. Guelfi,et al.  Hedonic response to sucrose solutions and the fear of weight gain in patients with eating disorders , 2002, Psychiatry Research.

[18]  T. Bonner,et al.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M Czosnyka,et al.  Cerebral autoregulation in carotid artery occlusive disease assessed from spontaneous blood pressure fluctuations by the correlation coefficient index. , 2003, Stroke.

[20]  D. Newell,et al.  Intraoperative use of transcranial Doppler ultrasonography. , 1996, Neurosurgery clinics of North America.

[21]  C. Hillard Endocannabinoids and vascular function. , 2000, The Journal of pharmacology and experimental therapeutics.

[22]  K I Bolla,et al.  Dose-related neurocognitive effects of marijuana use , 2002, Neurology.

[23]  R. Herning,et al.  Tetrahydrocannabinol content and differences in marijuana smoking behavior , 2004, Psychopharmacology.

[24]  R. Nicoll,et al.  Endocannabinoid Signaling in the Brain , 2002, Science.